Press Releases GSK plc

Equities

GSK

GB00BN7SWP63

Real-time Estimate Cboe Europe Other stock markets 07:00:45 02/05/2024 pm IST			5-day change	1st Jan Change
1,717 ^GBX	+0.72%		+3.88%	+18.26%

01:42pm	GSK : Buy rating from Deutsche Bank	ZD
12:53pm	GSK : UBS keeps its Buy rating	ZD

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

GSK : Q1 2024 results transcript	05:21pm	PU
GSK : Q1 2024 results slides	03:05pm	PU
GSK : Q1 2024 results infographic	03:05pm	PU
Glaxo: Q1 Earnings Snapshot	01/05	AQ
US FDA accepts for priority review GSK's application for an expanded indication of Jemperli (dostarlimab) plus chemotherapy to include all adult patients with primary advanced or recurrent endometrial cancer \| GSK	24/04	AQ
GSK : Director/Pdmr Shareholding - Form 6-K	19/04	PU
EAGLE-1 phase III data show potential for gepotidacin as a new oral treatment option for uncomplicated urogenital gonorrhoea (GC) amid growing resistance to existing treatments \| GSK	17/04	AQ
New long-term data show Shingrix continues to provide high protection against shingles in adults aged 50 and over for more than a decade \| GSK	17/04	AQ
GSK : EAGLE-1 phase III data show potential for gepotidacin as a new oral treatment option for uncomplicated urogenital gonorrhoea (GC) amid growing resistance to existing treatments - Form 6-K	17/04	PU
GSK's 5-in-1 meningococcal ABCWY vaccine candidate accepted for regulatory review by US FDA \| GSK	17/04	AQ
GSK : EAGLE-1 phase III data show potential for gepotidacin as a new oral treatment option for uncomplicated urogenital gonorrhoea (GC) amid growing resistance to existing treatments	17/04	PU
GSK : New long-term data show Shingrix continues to provide high protection against shingles in adults aged 50 and over for more than a decade	17/04	PU
GSK : 5-in-1 meningococcal ABCWY vaccine candidate accepted for regulatory review by US FDA - Form 6-K	16/04	PU
GSK : 5-in-1 meningococcal ABCWY vaccine candidate accepted for regulatory review by US FDA	16/04	PU
GSK : Q1 2024 pre announcement aide memoire	12/04	PU
WuXi Biologics Reports Solid 2023 Annual Results	27/03	AQ
GSK : Director/Pdmr Shareholding - Form 6-K	22/03	PU
Haleon to buy shares from Pfizer as US pharma giant reduces its stake	19/03	AQ
GSK plc - Positive RUBY phase III data show potential for Jemperli combinations in more patients with primary advanced or recurrent endometrial cancer	18/03	AQ
Positive RUBY phase III data show potential for Jemperli (dostarlimab-gxly) combinations in more patients with primary advanced or recurrent endometrial cancer	16/03	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

GSK PLC : Encouraging start to 2024; guidance raised

May 01, 2024 at 09:08 pm IST